CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - Management
Drug interactions with the combined contraceptive patch: how should I manage?
- The efficacy of the combined contraceptive patch can be reduced by liver enzyme–inducing drugs (which include the antibiotics rifampicin and rifamycin) and non-liver enzyme–inducing antibiotics.
- Precautions to be taken are the same as for women taking a combined oral contraceptive (COC). For further information, see Drug interactions (for a COC).
In depth
© NHS Institute for Innovation and Improvement